HPLC Method Optimation of α-mangostin Assay in Mangosteen (Garcinia mangostana L.) Fruit Rind Extract Formulated in Oral Solution

Similar documents
Received: 21 Aug 2009 Sudarshan Institute of Technical Education Pvt. Ltd.

Muchtaridi Muchtaridi 1*, Nadia Ananda Puteri 1, Tiana Milanda 2, Ida Musfiroh 1 ABSTRACT ARTICLE INFO

RP-HPLC Method Development and Validation of Abacavir Sulphate in Bulk and Tablet Dosage Form

Development and Validation for Simultaneous Estimation of Sitagliptin and Metformin in Pharmaceutical Dosage Form using RP-HPLC Method

Determination of Glabridin in Licorice Root (Glycyrrhiza glabral.) Using High Performance Liquid Chromatography

SUMMARY, CONCLUSION & RECOMMENDATIONS

Journal of Chemical and Pharmaceutical Research

SIMULTANEOUS ESTIMATION OF VALSARTAN AND HYDROCHLOROTHIAZIDE IN TABLETS BY RP-HPLC METHOD

DEVELOPMENT OF RP-HPLC METHOD FOR ESTIMATION OF DROTAVERINE HYDROCHLORIDE IN PHARMACEUTICAL FORMULATIONS

Application Note. Agilent Application Solution Analysis of ascorbic acid, citric acid and benzoic acid in orange juice. Author. Abstract.

Pankti M. Shah et al, Asian Journal of Pharmaceutical Technology & Innovation, 04 (17); 2016; 07-16

Effective use of Pharmacopeia guidelines to reduce cost of chromatographic analysis for Fluticasone propionate

Lutein Content Analysis in Green and Red Spinach (Amaranthus tricolor L.) by Visible Spectrophotometry. Abstract

Scholars Research Library. Der Pharmacia Lettre, 2016, 8 (6): (

Pelagia Research Library

F. Al-Rimawi* Faculty of Science and Technology, Al-Quds University, P.O. Box 20002, East Jerusalem. Abstract

Pelagia Research Library

DEVELOPMENT AND VALIDATION OF RP-HPLC METHOD FOR QUANTITATIVE ANALYSIS TOLBUTAMIDE IN PURE AND PHARMACEUTICAL FORMULATIONS

RP- HPLC and Visible Spectrophotometric methods for the Estimation of Meropenem in Pure and Pharmaceutical Formulations

Development and Validation of Improved RP-HPLC method for Identification and Estimation of Ellagic and Gallic acid in Triphala churna

METHOD DEVELOPMENT AND VALIDATION BY RP-HPLC FOR ESTIMATION OF ZOLPIDEM TARTARATE

CHAPTER 8 HIGH PERFORMANCE LIQUID CHROMATOGRAPHY (HPLC) ANALYSIS OF PHYTOCHEMICAL CONSTITUENTS OF M. ROXBURGHIANUS AND P. FRATERNUS PLANT EXTRACTS

SIMULTANEOUS DETERMINATION OF ATORVASTATIN AND EZETIMIBE BY RP-HPLC IN PURE AND PHARMACEUTICAL DOSAGE FORM

ISSN: ; CODEN ECJHAO E-Journal of Chemistry 2011, 8(3),

Hyderabad, India. Department of Pharmaceutical Chemistry, Glocal University, Saharanpur, India.

Rapid Gradient and Elevated Temperature UHPLC of Flavonoids in Citrus Fruit

J Pharm Sci Bioscientific Res (4): ISSN NO

Volume 2 (6), 2014, Page CODEN (USA)-IJPRUR, e-issn: International Journal of Pharma Research and Health Sciences

Asian Journal of Pharmaceutical Analysis and Medicinal Chemistry Journal home page:

Ultra High Performance Liquid Chromatograph. Nexera X2 C196-E079

Available online at Scholars Research Library

DEVELOPMENT AND VALIDATION OF RP-HPLC METHOD FOR QUANTITATIVE ANALYSIS OF TRAMADOL IN PURE AND PHARMACEUTICAL FORMULATIONS

Stability indicating RP-HPLC method for simultaneous determination of Beclomethasone Dipropionate and Clotrimazole from dosage form

Development, Estimation and Validation of Lisinopril in Bulk and its Pharmaceutical Formulation by HPLC Method

Simultaneous Estimation of Lamivudine and Stavudine by using RP-HPLC and Method Development as per ICH Guidelines

Development of a Validated RP-HPLC Method for the Analysis of Citicoline Sodium in Pharmaceutical Dosage Form using Internal Standard Method

Qualitative and quantitative determination of phenolic antioxidant compounds in red wine and fruit juice with the Agilent 1290 Infinity 2D-LC Solution

ISSN (Print)

Amudha S et al., Asian Journal of Pharmthiaceutical Technology & Innovation, 04 (21); 2016; Research Article

Available online Research Article

Available online Research Article

Validated RP- HPLC Method for the Quantitative Estimation of Valsartan in Bulk and Pharmaceutical Dosage Forms

CHAPTER-2. Table of Contents. S.No. Name of the Sub-Title Page No. 2.1 Literature survey for simultaneous estimation of selected drugs by RP-HPLC

A New Stability-Indicating and Validated RP-HPLC Method for the Estimation of Liraglutide in Bulk and Pharmaceutical Dosage Forms

AMERICAN JOURNAL OF BIOLOGICAL AND PHARMACEUTICAL RESEARCH

DEVELOPMENT AND VALIDATION OF RP-HPLC METHOD ESTIMATION OF TOLVAPTAN IN BULK PHARMACEUTICAL FORMULATION

A HIGH PERFORMANCE LIQUID CHROMATOGRAPHIC ASSAY FOR LERCANIDIPINE HYDROCHLORIDE

New RP-HPLC Method for the Determination of Fludarabine in Pharmaceutical Dosage Forms

Optimization of extraction method and profiling of plant phenolic compounds through RP-HPLC

DETERMINATION OF LOTEPREDNOL ETABONATE AND TOBRAMYCIN IN COMBINED DOSAGE FORM USING RP-HPLC METHOD

Tentu Nageswara Rao et al. / Int. Res J Pharm. App Sci., 2012; 2(4): 35-40

Scholars Research Library

CHAPTER INTRODUCTION OF DOSAGE FORM AND LITERATURE REVIEW

Isolation of five carotenoid compounds from tangerine tomatoes

C30 ISOMERS HAVE MET THEIR MATCH

A simple validated RP-HPLC method for quantification of sumatriptan succinate in bulk and pharmaceutical dosage form

IJPAR Vol.3 Issue 4 Oct-Dec-2014 Journal Home page:

Achiral SFC: Development of an Orthogonal SFC Method for Mometasone Furoate Impurity Analysis


Development of RP-HPLC Method for Estimation of Valsartan and Hydrochlorothiazide in Tablets

Ankit et al Journal of Drug Delivery & Therapeutics; 2013, 3(2), Available online at RESEARCH ARTICLE

DEVELOPMENT AND VALIDATION OF RP-HPLC METHOD FOR ESTIMATION OF LACOSAMIDE IN BULK AND ITS PHARMACEUTICAL FORMULATION

DEVELOPMENT AND VALIDATION OF RP-HPLC METHOD FOR SIMULTANEOUS ESTIMATION OF ETORICOXIB AND THIOCOLCHICOSIDE IN PHARMACEUTICAL DOSAGE FORMS

Simultaneous determination of triacetin, acetic ether, butyl acetate and amorolfine hydrochloride in amorolfine liniment by HPLC

Simultaneous Estimation of Gemcitabine Hydrochloride and Capecitabine Hydrochloride in Combined Tablet Dosage Form by RP-HPLC Method

Probing for Packaging Migrants in a Pharmaceutical Impurities Assay Using UHPLC with UV and Mass Detection INTRODUCTION

NOVEL RP-HPLC METHOD. B.Lakshmi et a. concentration range KEY INTRODUCTION. Diltiazem is used to. . It works by of contractionn of the. (dilate).

International Journal of Pharma and Bio Sciences DEVELOPMENT AND VALIDATION OF RP-HPLC METHOD FOR THE ESTIMATION OF STRONTIUM RANELATE IN SACHET

Asian Journal of Pharmaceutical Analysis and Medicinal Chemistry Journal home page:

Stability indicating RP-HPLC method development and validation of Etizolam and Propranolol hydrochloride in pharmaceutical dosage form

CHAPTER INTRODUCTION OF DOSAGE FORM AND LITERATURE REVIEW

Rebaudioside a From Multiple Gene Donors Expressed in Yarrowia Lipolytica

Reverse Phase HPLC Analysis of Atomoxetine in Pharmaceutical Dosage Forms

Pelagia Research Library

A Validated Chiral Liquid Chromatographic Method for The Enantiomeric Separation of Dapoxetine Hydrochloride

Development and validation of related substances method for Varenicline and its impurities

Corresponding Author:

Comprehensive Two-Dimensional HPLC and Informative Data Processing for Pharmaceuticals and Lipids

INTRODUCTION. safety and efficacy throughout all phases of its shelf life, including storage. In

An Investigative Study of Reactions Involving Glucosinolates and Isothiocyanates

Journal of Pharmacreations

Analytical Method Development for USP Related Compounds in Paclitaxel Using an Agilent Poroshell 120 PFP

A Reverse Phase HPLC Method Development and Validation for the Determination of Paliperidone in Pure and Dosage Forms

ASSAY AND IMPURITY METHOD FOR DURACOR TABLETS BY HPLC

Validation of Changes to the USP Assay Method for Ibuprofen Tablets

Available online Research Article

Scholars Research Library. Der Pharmacia Lettre, 2015, 7 (5):44-49 (

International Journal of Innovative Pharmaceutical Sciences and Research

Separation of Macrocyclic Lactones (Avermectins) on FLARE C18 MM & FLARE C18+ Columns

RP-HPLC METHOD DEVELOPMENT AND VALIDATION FOR THE ESTIMATION OF BACLOFEN IN BULK AND PHARMACEUTICAL DOSAGE FORMS

Extended Application Note

Development and Validation of RP-HPLC Method for the Simultaneous Estimation of Avibactam and Ceftazidime in Bulk drug and injection dosage Form

International Journal of PharmTech Research CODEN (USA): IJPRIF, ISSN: Vol.8, No.2, pp , 2015

International Journal of Pharmacy and Pharmaceutical Sciences. Research Article

Development and validation of liquid chromatographic method for trazodone hydrochloride

Analysis of Common Sweeteners and Additives in Beverages with the PerkinElmer Flexar FX-15 System Equipped with a PDA Detector

Development and validation of RP-HPLC method for simultaneous estimation of gliclazide and metformin in pure and tablet dosage form

International Journal of Farmacia

DEVELOPMENT AND VALIDATION OF STABILITY INDICATING RP-HPLC METHOD FOR SIMULTANEOUS ESTIMATION OF ROSUVASTATIN CALCIUM AND ASPIRIN IN

RITONAVIRI COMPRESSI RITONAVIR TABLETS. Final text for addition to The International Pharmacopoeia (July 2012)

Transcription:

HPLC Method Optimation of α-mangostin Assay in Mangosteen (Garcinia mangostana L.) Fruit Rind Extract Formulated in Oral Solution Liliek Nurhidayati*, Siti Sofiah, Ros Sumarny, Kevin Caesar Faculty of Pharmacy, Pancasila University, Jakarta *Corresponding author, email: liliek_nurhidayati@yahoo.com Abstract Antioxidant from natural ingredients is important to reduce an incident of degenerative diseases and to prevent free radicals. One of them is mangosteen fruit rind which is rich in antioxidants, especially α-mangostin as a major component. The developed formulation of oral solution contains mangosteen fruit rind extract that needs an assay method for quality testing. The α-mangostin compound can be used as chemical marker. To determine a very low concentration of analyte in sample with very complex matrix, such as in oral solution, it needs a selective and sensitive method, that can be obtained in high performance liquid chromatography (HPLC). In this study, α-mangostin assay was performed by RP-HPLC system using octadecylsilane (C18) stationary phase with various ratios of mobile phase and flow rate. The best result are given by system with methanol-water (90:10) as mobile phase, flow rate of 1.0 ml/min, and UV detector at 316 nm. In addition, the retention time of α- mangostin was 9.622 minutes. Keywords: α-mangostin, Garcinia mangostana L., assay, oral solution, HPLC INTRODUCTION One of the compound from Garcinia mangostana rind extract that has antioxidant activity is α-mangostin. Oral solution formulation of Garcinia mangostana rind extract has been done using cosolvency method. Based on α-mangostin solubility the best choise was obtained with PEG 400 and glycerin of 40% (Sofiah et al., 2013). In this oral solution there are Garcinia mangostana rind extract and excipient that are very complex. To analyse the α-mangostin in this oral solution, it need such a specific and sensitive method. It is high performance liquid chromatography (HPLC). This method had been used to assay α-mangostin in Garcinia mangostana rind extract (Aisha et al., 2013; Yodhnu et al., 2009; Pothitirat and Gritsanapan, 2009; Islam and Begum, 2011; Jujun et al., 2009), after extract encapsulation in PLGA (Poly Lactic-co-Glycolic Acid) microspheres (Ali et al., 2012), and in plasma blood rat (Syamsudin et al., 2010). In this research, optimation of HPLC condition was done using various mobile phase, flow rate and detector.

MATERIAL AND METHODS α-mangostin standard compound was purchased from Chengdu Biopurify Phytochemicals Ltd. Oral solution of mangosteen (Garcinia mangostana L.) fruit rind extract was prepared using cosolvency methods (Sofiah et al, 2013). Determination of maximum absorption of α-mangostin Determination of maximum absorption was conducted with recording of absorption spectra at 20 ppm of α-mangostin standard solution in the region of 200-500 nm using Shimadzu UV-1800 spectrophotometry. Determination of HPLC optimum condition This assay was conducted using Shimadzu LC-20AD, with octadecylsilane (C18) Shim-pack VP-ODS 94.6 x 250 mm; 4.6 μm at the themperature of 40 o C. Based on previous research (Aisha et al., 2013; Yodhnu et al., 2009; Pothitirat and Gritsanapan, 2009; Islam and Begum, 2011; Jujun et al., 2009; Teixeira et al., 2003) the various mobile phase and flow rate with some modification were performed to choose the best condition. The solvent system are acetonitrile-0.1% of ortho phosphoric acid in water and methanol-water. RESULTS AND DISCUSSION Maximum wavelength of α-mangostin UV spectrum of α-mangostin in the region of 200-500 nm are seen on Fig. 1. Figure 1. UV spectra of α-mangostin standard solution

There are 2 maximum wavelength, namely 243.2 nm and 316.4 nm. These two maximum wavelength were similar with those of Aisha et al. (2013). The wavelength of 316 nm were choosed as detector in HPLC because the use of 244 nm as detector could disturb baseline stabilization, raise such noise and ghost peak when using methanol as mobile phase. In addition, 316.4 nm need lower energy than 243.2 nm. Determination of HPLC optimum condition Optimum condition was made from various mobile phase using the flow rate of 1.0 ml/minute. If there is low resolution, the flow rate was 0.8 ml/minute and if the retention time was long it was adjusted in 1.2 ml/minute. The colomn was the same in all condition namely octadecylsilane (C18) Shim-pack VP-ODS with dimension of 4.6 x 250 mm; 4.6 μm, colomn themperature of 40 o C, and using 316 nm as detector. First experiment was done using mobile phase of acetonitrile-0.1% ortho phosphoric acid in water (95:5). The result could be seen as follows. Figure 2. α- mangostin (a) and oral solution chromatograms (b) using mobile phase of acetonitrile- 0.1% ortho phosphoric acid in water (95:5) with flow rate of 1.0 ml/minute Fig 2. Showed that with flow rate of 1.0 ml/minute the retention time of α-mangostin was 5.331 minute. It was quite fast. In oral solution chromatogram, α-mangostin peak wasn t separated with the other compounds. α-mangostin standard chromatogram showed two peaks. Using 0.8 ml/minute of flow rate, α-mangostin has two peaks with the retention time of major peak was 6.664 minute (Fig. 3 a). The peak of α-mangostin in the oral solution is not separated well. So It was not the candidate of the mobile phase for HPLC.

Figure 3. α- mangostin (a) and oral solution chromatograms (b) using mobile phase of acetonitrile- 0.1% ortho phosphoric acid in water (95:5) with flow rate of 0.8 ml/minute The next experiment was conducted using mobile phase of acetonitrile-0.1% ortho phosphoric acid in water (75:25). The chromatograms were showed as Fig 4 and Fig. 5. Figure 4. α- mangostin (a) and oral solution chromatograms (b) using mobile phase of acetonitrile-0.1% ortho phosphoric acid in water (75:25) with flow rate of 1.0 ml/minute Figure 5. α- mangostin (a) and oral solution chromatograms (b) using mobile phase of acetonitrile-0.1% ortho phosphoric acid in water (75:25) with flow rate of 1.2 ml/minute

Fig 4. Shows that α-mangostin chromatogram has the retention time of 14.123 minute. α-mangostin peak was separated well with the others (b) but α- mangostin peak was splitted. To know whether the retention time of α-mangostin will be shorter and still well separated the flow rate is conducted in flow rate of 1.2 ml/minute. In this condition α-mangostin has the retention time of 11.848 minute (Fig. 5 a), well separated in the oral solution but there is another peak in α- mangostin standard chromatogram. Tailing could interfere the α-mangostin area so that in the assay there is no accuracy. The other mobile phase was methanol-water (95:5). In this condition α- mangostin peak was detected with a retention time of 5.797 minute for reference standards (Fig. 6 a) and 5.990 minute for oral solution (Fig. 6 b). The retention time is quite fast. However, the α-mangostin peak in the oral solution are not separated properly. In addition, the tailing factor of α-mangostin peaks on the chromatogram reference standard is too large, ie 2.085 (more than 2.0). Tailing factor that can generate large peak area values are less accurate. Slower flow rate was applied to see if α-mangostin peak in the oral solution can be well separated and the tailing factor of α-mangostin peaks on the reference standard chromatogram may be lower. Figure 6. α- mangostin (a) and oral solution chromatograms (b) using mobile phase of methanol-water (95:5) with flow rate of 1.0 ml/minute Experiments using this mobile phase with a flow rate of 0.8 ml/minute generated chromatogram as seen in Fig 7. α-mangostin peak was detected with a retention time of 7.343 minute for reference standard (Fig. 7 a) and 7.441 minute for oral solution (Fig 7 b). Retention time is still quite fast. However, the peak of α-mangostin in the oral solution is still not well separated although the tailing factor of α-

mangostin peaks on the chromatogram reference standard has been reduced to 1.741 (less than 2.0). Thus, the mobile phase can not be a candidate for the selected mobile phase. Figure 7. α- mangostin (a) and oral solution chromatograms (b) using mobile phase of methanol-water (95:5) with flow rate of 0.8 ml/minute Another tested mobile phase was methanol-water (90:10). Experiments using this mobile phase with a flow rate of 1.0 ml / minute generated chromatogram as follows. a. B. Figure. 8. α- mangostin (a) and oral solution chromatograms (b) using mobile phase of in mobile phase of methanol-water (90:10) with a flow rate of 1.0 ml / minute α-mangostin peak was detected with a retention time of 9.622 minute for reference standards and 9.807 minute for oral solution (Fig 8 a and b). Peak of α-mangostin in the oral solution was well separated with resolution of 1.725 (better than 1.5) that fulfil the criteria of the specificity test. The tailing factor of α-mangostin peaks on the reference standard chromatogram is 1.213 and 1.378 on the oral solution chromatogram. The faster flow rates was tested in order the retention time of α-

mangostin can be more quick and remain well separated in the oral solution. Using the same mobile phase with flow rate of 1.2 ml/minute, generated chromatogram was follows. Figure. 9. α- mangostin (a) and oral solution chromatograms (b) using mobile phase of methanol-water (90:10) with a flow rate of 1.2 ml / minute α-mangostin peak was detected with a retention time of 8.230 minute for reference standard (Fig. 9 a) and 8.342 minute for oral solution (Fig. 9.b). Peak of α-mangostin in the oral solution remains well separated with resolution more than 1.5, the tailing factor of α-mangostin peaks on the reference standard chromatogram was 1.269 and 1.291 on the oral solution. Thus, the mobile phase may be a candidate for the selected HPLC mobile phase. Based on 4 mobile phases, methanol-water (90:10) was the only candidate HPLC mobile phase for selected conditions. This is advantageous because composition of methanol in the mobile phase is lower than the mobile phase of methanol-water other tried and not using acetonitrile (less expensive and less toxic). In addition, the mobile phase is simple because it contains only two components (methanol and water) and do not need the buffer. Flow rate tested with the mobile phase was 1.0 ml/minute and 1.2 ml/minute. The results showed a good separation (high resolution) and low tailing factor. HPLC conditions used for the selected flow rate 1.0 ml/minute with the following considerations. Burden of pumps used is more heavily if the flow rate is 1.2 ml/minute. On the use of a flow rate of 1.0 ml/minute time required for data acquisition (acquisition time) was 12.5 minute while the use of a flow rate of 1.2 ml/ minute is 11 minute. The volume of the mobile phase with a flow rate of 1.0 ml/ minute was 12.5 ml and a flow rate of 1.2 ml/minute needs 13.2 ml of mobile

phase. Therefore, for routine analysis would be more efficient to use a flow rate of 1.0 ml / minute. CONCLUSION The optimum HPLC conditions that can be used for analysis of α-mangostin in the oral solution of mangosteen fruit rind extract are octadecylsilane stationary phase (C18), mobile phase of methanol-water (90:10) with flow rate of 1.0 ml / minute, and detector of 316 nm. ACKNOWLEDGMENT The Authors are Grateful to Ditlitabmas Ditjend Dikti for Hibah Bersaing research funding as DIPA Kopertis Wilayah III Number 023.04.2.189705/2013. REFERENCES Aisha AFA, Abu-Salah KM, Ismail Z, Majid AMSA. 2013. Determination of total xanthones in Garcinia mangostana fruit rind extracts by ultraviolet (UV) spectrophotometry. J Med Plants Res, 7(1):29-35. Aisha AFA, Abu-Salah KM, Siddiqui MJ, Ismail Z, Majid AMSA. 2012. Quantification of α-, β- and γ-mangostin in Garcinia mangostana fruit rind extracts by a reverse phase high performance liquid chromatography. J Med Plants Res,6(29):4526-34. Ali AAE, Taher M, Helaluddin ABM, Mohamed F. 2012. Development and validation of analytical method by RP-HPLC for quantification of alpha-mangostin encapsulated in PLGA microspheres. J Anal Bioanal Teq (2155-9872 JABT).3(7) Islam MA, Begum S. 2011. Quantitative analysis of α-mangostin in mangosteen fruit rind extract. Int J Agril Res Innov & Tech. 1(1&2):55-59. Jujun P, Pootakham K, Pongpaibul Y, Tharavichitkul P, Ampasavate C. 2009. HPLC determination of mangostin and its application to storage stability study. J Nat Sci.8(1):43-53. Pothitirat W, Gritsanapan W. 2009. HPLC quantitative analysis method for the determination of α-mangostin in mangosteen fruit rind extract. Thai J Agri Scie. 42(1):7-12. Rohman A. 2009. Kromatografi untuk analisis obat. Yogyakarta: Graha Ilmu; p. 111-6,217-30. Sofiah S, Sumarny R, Nurhidayati L. 2013. Teknologi Kosolvensi pada Formulasi Sediaan Larutan Oral Ekstrak Kulit Buah Manggis (Garcinia mangostana L) sebagai Antioksidan. Laporan Penelitian. Fakultas Farmasi Universitas Pancasila. Jakarta.

Syamsudin, Faizatun, Rahayu L. 2010. HPLC analysis and pharmacokinetic study of mangostin after orally administration in rats. Int J of Pharm and Bio Scie. 1(1):1-7. Teixeira M, Afonso C, Pinto M, Barbosa CM. 2003. A validated HPLC method for the assay of xanthone and 3-methoxyxanthone in PLGA nanocapsules. J Chrom Scie.41:371-6. Yodhnu S, Sirikatitham A, Wattanapiromsakul C. 2009. Validation of LC for the determination of α-mangostin in mangosteen peel extract: a tool for quality assessment of Garcinia mangostana L. J Chrom Scie. 47:185-9.